Title: GMPs Guide COVID-19 Vaccine Manufacturing

Recent industry guidance aims to anchor rapid COVID-19 vaccine development in good manufacturing practice protocols. Major bio/pharmaceutical companies and contract service providers leading the charge to bring COVID-19 vaccines to market are familiar with established good manufacturing practices (GMPs). To support manufacturers in the rush to develop a vaccine, FDA, in June 2020, released industry guidance highlighting the development and licensure of COVID-19 vaccines.

Click Here For Complete Article Text


   Person Information
   Application Sequencing
 325412 - Pharmaceutical Preparation Manufacturing                
 541711 - Research and Development in Biotechnology                
Company  Product  Process  Other  Subjects  Event  Event  Date  Location  Publication  Publication  Date Text  Descriptor
  • Contamination Control

  • Manufacturing


  • Standards




  • Pharmaceutical Technology


  • 11/2/2020


  • Article